CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.

MLA

M, Hesse L., et al. “CYP2B6 Mediates the in Vitro Hydroxylation of Bupropion: Potential Drug Interactions with Other Antidepressants.” Drug Metabolism and Disposition, vol. 28, no. 10, Oct. 2000, pp. 1176–83. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs5545104&authtype=sso&custid=ns315887.

APA

M, H. L., K, V., H, C. M., L, von M. L., X, D. S., I, S. R., & J, G. D. (2000). CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants. Drug Metabolism and Disposition, 28(10), 1176–1183.

Chicago

M, Hesse L, Venkatakrishnan K, Court M H, von Moltke L L, Duan S X, Shader R I, and Greenblatt D J. 2000. “CYP2B6 Mediates the in Vitro Hydroxylation of Bupropion: Potential Drug Interactions with Other Antidepressants.” Drug Metabolism and Disposition 28 (10): 1176–83. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs5545104&authtype=sso&custid=ns315887.